Network meta-analysis of the benefit of aspirin with rivaroxaban vs. clopidogrel for patients with stable symptomatic lower extremity arterial disease

Graeme K Ambler, Joakim Nordanstig, Christian-Alexander Behrendt, Chris P Twine

Research output: Contribution to journalArticle (Academic Journal)peer-review

Original languageEnglish
JournalEuropean Journal of Vascular and Endovascular Surgery
Publication statusAccepted/In press - 1 Jun 2021


  • Peripheral Arterial Disease / drug therapy
  • drug therapy, combination
  • platelet aggregation inhibitors / therapeutic use
  • Randomised controlled trials as topic
  • secondary prevention

Cite this